nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—lung cancer	0.23	1	CbGaD
Etravirine—CYP2C19—Gefitinib—lung cancer	0.0349	0.0683	CbGbCtD
Etravirine—CYP2C19—Teniposide—lung cancer	0.0338	0.0663	CbGbCtD
Etravirine—ABCB1—Topotecan—lung cancer	0.0308	0.0603	CbGbCtD
Etravirine—CYP2C9—Gefitinib—lung cancer	0.029	0.0568	CbGbCtD
Etravirine—ABCB1—Gefitinib—lung cancer	0.0282	0.0551	CbGbCtD
Etravirine—CYP2C9—Teniposide—lung cancer	0.0281	0.0551	CbGbCtD
Etravirine—ABCB1—Vinorelbine—lung cancer	0.0217	0.0425	CbGbCtD
Etravirine—CYP3A4—Topotecan—lung cancer	0.0184	0.0361	CbGbCtD
Etravirine—ABCB1—Crizotinib—lung cancer	0.0173	0.0338	CbGbCtD
Etravirine—CYP3A4—Gefitinib—lung cancer	0.0169	0.033	CbGbCtD
Etravirine—ABCB1—Gemcitabine—lung cancer	0.0169	0.033	CbGbCtD
Etravirine—ABCB1—Erlotinib—lung cancer	0.0166	0.0326	CbGbCtD
Etravirine—CYP3A4—Teniposide—lung cancer	0.0164	0.032	CbGbCtD
Etravirine—CYP2C9—Paclitaxel—lung cancer	0.0157	0.0308	CbGbCtD
Etravirine—ABCB1—Paclitaxel—lung cancer	0.0152	0.0298	CbGbCtD
Etravirine—ABCB1—Irinotecan—lung cancer	0.015	0.0294	CbGbCtD
Etravirine—ABCB1—Vinblastine—lung cancer	0.0134	0.0262	CbGbCtD
Etravirine—CYP3A4—Vinorelbine—lung cancer	0.013	0.0255	CbGbCtD
Etravirine—CYP2C9—Cisplatin—lung cancer	0.0126	0.0247	CbGbCtD
Etravirine—ABCB1—Cisplatin—lung cancer	0.0123	0.024	CbGbCtD
Etravirine—ABCB1—Etoposide—lung cancer	0.012	0.0236	CbGbCtD
Etravirine—ABCB1—Docetaxel—lung cancer	0.011	0.0216	CbGbCtD
Etravirine—CYP3A4—Crizotinib—lung cancer	0.0103	0.0203	CbGbCtD
Etravirine—CYP3A4—Erlotinib—lung cancer	0.00998	0.0195	CbGbCtD
Etravirine—CYP3A4—Paclitaxel—lung cancer	0.00913	0.0179	CbGbCtD
Etravirine—CYP3A4—Irinotecan—lung cancer	0.00901	0.0176	CbGbCtD
Etravirine—ABCB1—Doxorubicin—lung cancer	0.00821	0.0161	CbGbCtD
Etravirine—CYP3A4—Vinblastine—lung cancer	0.00801	0.0157	CbGbCtD
Etravirine—ABCB1—Methotrexate—lung cancer	0.00796	0.0156	CbGbCtD
Etravirine—CYP3A4—Etoposide—lung cancer	0.00722	0.0141	CbGbCtD
Etravirine—CYP3A4—Docetaxel—lung cancer	0.0066	0.0129	CbGbCtD
Etravirine—CYP3A4—Doxorubicin—lung cancer	0.00492	0.00964	CbGbCtD
Etravirine—Rilpivirine—ABCG2—lung cancer	0.00237	0.706	CrCbGaD
Etravirine—Rilpivirine—ABCB1—lung cancer	0.000986	0.294	CrCbGaD
Etravirine—Paraesthesia—Cisplatin—lung cancer	0.000123	0.000687	CcSEcCtD
Etravirine—Thrombocytopenia—Etoposide—lung cancer	0.000123	0.000686	CcSEcCtD
Etravirine—Infection—Paclitaxel—lung cancer	0.000122	0.000683	CcSEcCtD
Etravirine—Skin disorder—Etoposide—lung cancer	0.000122	0.000681	CcSEcCtD
Etravirine—Dry skin—Doxorubicin—lung cancer	0.000121	0.000678	CcSEcCtD
Etravirine—Hyperhidrosis—Etoposide—lung cancer	0.000121	0.000677	CcSEcCtD
Etravirine—Feeling abnormal—Gemcitabine—lung cancer	0.000121	0.000676	CcSEcCtD
Etravirine—Shock—Paclitaxel—lung cancer	0.000121	0.000676	CcSEcCtD
Etravirine—Dizziness—Vinorelbine—lung cancer	0.000121	0.000675	CcSEcCtD
Etravirine—Nervous system disorder—Paclitaxel—lung cancer	0.00012	0.000674	CcSEcCtD
Etravirine—Thrombocytopenia—Paclitaxel—lung cancer	0.00012	0.000673	CcSEcCtD
Etravirine—Breast disorder—Doxorubicin—lung cancer	0.000119	0.000668	CcSEcCtD
Etravirine—Anorexia—Etoposide—lung cancer	0.000119	0.000668	CcSEcCtD
Etravirine—Skin disorder—Paclitaxel—lung cancer	0.000119	0.000667	CcSEcCtD
Etravirine—Abdominal pain—Irinotecan—lung cancer	0.000119	0.000666	CcSEcCtD
Etravirine—Body temperature increased—Irinotecan—lung cancer	0.000119	0.000666	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000119	0.000666	CcSEcCtD
Etravirine—Decreased appetite—Cisplatin—lung cancer	0.000119	0.000665	CcSEcCtD
Etravirine—Hyperhidrosis—Paclitaxel—lung cancer	0.000119	0.000664	CcSEcCtD
Etravirine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000118	0.00066	CcSEcCtD
Etravirine—Anaemia—Docetaxel—lung cancer	0.000118	0.00066	CcSEcCtD
Etravirine—Anorexia—Paclitaxel—lung cancer	0.000117	0.000655	CcSEcCtD
Etravirine—Gastritis—Doxorubicin—lung cancer	0.000117	0.000654	CcSEcCtD
Etravirine—Pain—Cisplatin—lung cancer	0.000117	0.000654	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000117	0.000652	CcSEcCtD
Etravirine—Vomiting—Vinorelbine—lung cancer	0.000116	0.000649	CcSEcCtD
Etravirine—Body temperature increased—Gemcitabine—lung cancer	0.000116	0.000649	CcSEcCtD
Etravirine—Renal failure—Methotrexate—lung cancer	0.000116	0.000647	CcSEcCtD
Etravirine—Rash—Vinorelbine—lung cancer	0.000115	0.000644	CcSEcCtD
Etravirine—Dermatitis—Vinorelbine—lung cancer	0.000115	0.000643	CcSEcCtD
Etravirine—Abdominal distension—Doxorubicin—lung cancer	0.000115	0.000643	CcSEcCtD
Etravirine—Stomatitis—Methotrexate—lung cancer	0.000115	0.000642	CcSEcCtD
Etravirine—Headache—Vinorelbine—lung cancer	0.000114	0.00064	CcSEcCtD
Etravirine—Syncope—Docetaxel—lung cancer	0.000114	0.00064	CcSEcCtD
Etravirine—Conjunctivitis—Methotrexate—lung cancer	0.000114	0.00064	CcSEcCtD
Etravirine—Eosinophilia—Doxorubicin—lung cancer	0.000113	0.000633	CcSEcCtD
Etravirine—Feeling abnormal—Cisplatin—lung cancer	0.000113	0.00063	CcSEcCtD
Etravirine—Paraesthesia—Etoposide—lung cancer	0.000112	0.000629	CcSEcCtD
Etravirine—Loss of consciousness—Docetaxel—lung cancer	0.000112	0.000627	CcSEcCtD
Etravirine—Pancreatitis—Doxorubicin—lung cancer	0.000112	0.000627	CcSEcCtD
Etravirine—Somnolence—Etoposide—lung cancer	0.000111	0.000623	CcSEcCtD
Etravirine—Angina pectoris—Doxorubicin—lung cancer	0.000111	0.000623	CcSEcCtD
Etravirine—Hepatobiliary disease—Methotrexate—lung cancer	0.000111	0.000622	CcSEcCtD
Etravirine—Insomnia—Paclitaxel—lung cancer	0.000111	0.000621	CcSEcCtD
Etravirine—Hypersensitivity—Irinotecan—lung cancer	0.000111	0.000621	CcSEcCtD
Etravirine—Convulsion—Docetaxel—lung cancer	0.000111	0.000618	CcSEcCtD
Etravirine—Paraesthesia—Paclitaxel—lung cancer	0.00011	0.000617	CcSEcCtD
Etravirine—Hypertension—Docetaxel—lung cancer	0.00011	0.000616	CcSEcCtD
Etravirine—Somnolence—Paclitaxel—lung cancer	0.000109	0.000611	CcSEcCtD
Etravirine—Decreased appetite—Etoposide—lung cancer	0.000109	0.000609	CcSEcCtD
Etravirine—Nausea—Vinorelbine—lung cancer	0.000108	0.000607	CcSEcCtD
Etravirine—Gastrointestinal disorder—Etoposide—lung cancer	0.000108	0.000605	CcSEcCtD
Etravirine—Body temperature increased—Cisplatin—lung cancer	0.000108	0.000605	CcSEcCtD
Etravirine—Asthenia—Irinotecan—lung cancer	0.000108	0.000604	CcSEcCtD
Etravirine—Fatigue—Etoposide—lung cancer	0.000108	0.000604	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000108	0.000603	CcSEcCtD
Etravirine—Pain—Etoposide—lung cancer	0.000107	0.000599	CcSEcCtD
Etravirine—Constipation—Etoposide—lung cancer	0.000107	0.000599	CcSEcCtD
Etravirine—Decreased appetite—Paclitaxel—lung cancer	0.000107	0.000597	CcSEcCtD
Etravirine—Dry mouth—Docetaxel—lung cancer	0.000106	0.000594	CcSEcCtD
Etravirine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000106	0.000593	CcSEcCtD
Etravirine—Fatigue—Paclitaxel—lung cancer	0.000106	0.000592	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—lung cancer	0.000106	0.000591	CcSEcCtD
Etravirine—Asthenia—Gemcitabine—lung cancer	0.000105	0.000589	CcSEcCtD
Etravirine—Pain—Paclitaxel—lung cancer	0.000105	0.000588	CcSEcCtD
Etravirine—Constipation—Paclitaxel—lung cancer	0.000105	0.000588	CcSEcCtD
Etravirine—Confusional state—Docetaxel—lung cancer	0.000105	0.000587	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—lung cancer	0.000104	0.000583	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—lung cancer	0.000104	0.000579	CcSEcCtD
Etravirine—Infection—Docetaxel—lung cancer	0.000103	0.000579	CcSEcCtD
Etravirine—Feeling abnormal—Etoposide—lung cancer	0.000103	0.000577	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—lung cancer	0.000103	0.000577	CcSEcCtD
Etravirine—Diarrhoea—Irinotecan—lung cancer	0.000103	0.000576	CcSEcCtD
Etravirine—Gastrointestinal pain—Etoposide—lung cancer	0.000102	0.000573	CcSEcCtD
Etravirine—Shock—Docetaxel—lung cancer	0.000102	0.000573	CcSEcCtD
Etravirine—Nervous system disorder—Docetaxel—lung cancer	0.000102	0.000571	CcSEcCtD
Etravirine—Thrombocytopenia—Docetaxel—lung cancer	0.000102	0.00057	CcSEcCtD
Etravirine—Feeling abnormal—Paclitaxel—lung cancer	0.000101	0.000566	CcSEcCtD
Etravirine—Skin disorder—Docetaxel—lung cancer	0.000101	0.000566	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000101	0.000565	CcSEcCtD
Etravirine—Hypersensitivity—Cisplatin—lung cancer	0.000101	0.000564	CcSEcCtD
Etravirine—Gastrointestinal pain—Paclitaxel—lung cancer	0.0001	0.000562	CcSEcCtD
Etravirine—Diarrhoea—Gemcitabine—lung cancer	0.0001	0.000561	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—lung cancer	0.0001	0.00056	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—lung cancer	9.99e-05	0.000559	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—lung cancer	9.99e-05	0.000559	CcSEcCtD
Etravirine—Dizziness—Irinotecan—lung cancer	9.96e-05	0.000557	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—lung cancer	9.93e-05	0.000555	CcSEcCtD
Etravirine—Anorexia—Docetaxel—lung cancer	9.92e-05	0.000555	CcSEcCtD
Etravirine—Body temperature increased—Etoposide—lung cancer	9.9e-05	0.000554	CcSEcCtD
Etravirine—Abdominal pain—Etoposide—lung cancer	9.9e-05	0.000554	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—lung cancer	9.9e-05	0.000554	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—lung cancer	9.87e-05	0.000552	CcSEcCtD
Etravirine—Asthenia—Cisplatin—lung cancer	9.81e-05	0.000549	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—lung cancer	9.8e-05	0.000548	CcSEcCtD
Etravirine—Abdominal pain—Paclitaxel—lung cancer	9.71e-05	0.000543	CcSEcCtD
Etravirine—Body temperature increased—Paclitaxel—lung cancer	9.71e-05	0.000543	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—lung cancer	9.63e-05	0.000539	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—lung cancer	9.58e-05	0.000536	CcSEcCtD
Etravirine—Vomiting—Irinotecan—lung cancer	9.58e-05	0.000536	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—lung cancer	9.54e-05	0.000534	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—lung cancer	9.52e-05	0.000532	CcSEcCtD
Etravirine—Rash—Irinotecan—lung cancer	9.5e-05	0.000531	CcSEcCtD
Etravirine—Dermatitis—Irinotecan—lung cancer	9.49e-05	0.000531	CcSEcCtD
Etravirine—Headache—Irinotecan—lung cancer	9.43e-05	0.000528	CcSEcCtD
Etravirine—Insomnia—Docetaxel—lung cancer	9.42e-05	0.000527	CcSEcCtD
Etravirine—Diarrhoea—Cisplatin—lung cancer	9.36e-05	0.000523	CcSEcCtD
Etravirine—Paraesthesia—Docetaxel—lung cancer	9.35e-05	0.000523	CcSEcCtD
Etravirine—Vomiting—Gemcitabine—lung cancer	9.33e-05	0.000522	CcSEcCtD
Etravirine—Somnolence—Docetaxel—lung cancer	9.26e-05	0.000518	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—lung cancer	9.25e-05	0.000518	CcSEcCtD
Etravirine—Rash—Gemcitabine—lung cancer	9.25e-05	0.000517	CcSEcCtD
Etravirine—Dermatitis—Gemcitabine—lung cancer	9.24e-05	0.000517	CcSEcCtD
Etravirine—Hypersensitivity—Etoposide—lung cancer	9.23e-05	0.000516	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—lung cancer	9.19e-05	0.000514	CcSEcCtD
Etravirine—Headache—Gemcitabine—lung cancer	9.19e-05	0.000514	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—lung cancer	9.15e-05	0.000512	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—lung cancer	9.1e-05	0.000509	CcSEcCtD
Etravirine—Decreased appetite—Docetaxel—lung cancer	9.05e-05	0.000506	CcSEcCtD
Etravirine—Hypersensitivity—Paclitaxel—lung cancer	9.05e-05	0.000506	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—lung cancer	9.03e-05	0.000505	CcSEcCtD
Etravirine—Gastrointestinal disorder—Docetaxel—lung cancer	8.99e-05	0.000503	CcSEcCtD
Etravirine—Asthenia—Etoposide—lung cancer	8.99e-05	0.000503	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—lung cancer	8.99e-05	0.000503	CcSEcCtD
Etravirine—Fatigue—Docetaxel—lung cancer	8.98e-05	0.000502	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—lung cancer	8.96e-05	0.000501	CcSEcCtD
Etravirine—Nausea—Irinotecan—lung cancer	8.95e-05	0.0005	CcSEcCtD
Etravirine—Constipation—Docetaxel—lung cancer	8.9e-05	0.000498	CcSEcCtD
Etravirine—Pain—Docetaxel—lung cancer	8.9e-05	0.000498	CcSEcCtD
Etravirine—Asthenia—Paclitaxel—lung cancer	8.81e-05	0.000493	CcSEcCtD
Etravirine—Nausea—Gemcitabine—lung cancer	8.71e-05	0.000487	CcSEcCtD
Etravirine—Vomiting—Cisplatin—lung cancer	8.69e-05	0.000486	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—lung cancer	8.66e-05	0.000485	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—lung cancer	8.65e-05	0.000484	CcSEcCtD
Etravirine—Rash—Cisplatin—lung cancer	8.62e-05	0.000482	CcSEcCtD
Etravirine—Dermatitis—Cisplatin—lung cancer	8.61e-05	0.000482	CcSEcCtD
Etravirine—Feeling abnormal—Docetaxel—lung cancer	8.58e-05	0.00048	CcSEcCtD
Etravirine—Diarrhoea—Etoposide—lung cancer	8.57e-05	0.000479	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—lung cancer	8.55e-05	0.000478	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—lung cancer	8.53e-05	0.000477	CcSEcCtD
Etravirine—Gastrointestinal pain—Docetaxel—lung cancer	8.51e-05	0.000476	CcSEcCtD
Etravirine—Anaemia—Methotrexate—lung cancer	8.5e-05	0.000475	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—lung cancer	8.49e-05	0.000475	CcSEcCtD
Etravirine—Diarrhoea—Paclitaxel—lung cancer	8.4e-05	0.00047	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—lung cancer	8.3e-05	0.000464	CcSEcCtD
Etravirine—Malaise—Methotrexate—lung cancer	8.29e-05	0.000464	CcSEcCtD
Etravirine—Dizziness—Etoposide—lung cancer	8.28e-05	0.000463	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—lung cancer	8.26e-05	0.000462	CcSEcCtD
Etravirine—Vertigo—Methotrexate—lung cancer	8.26e-05	0.000462	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—lung cancer	8.24e-05	0.000461	CcSEcCtD
Etravirine—Abdominal pain—Docetaxel—lung cancer	8.23e-05	0.00046	CcSEcCtD
Etravirine—Body temperature increased—Docetaxel—lung cancer	8.23e-05	0.00046	CcSEcCtD
Etravirine—Dizziness—Paclitaxel—lung cancer	8.12e-05	0.000454	CcSEcCtD
Etravirine—Nausea—Cisplatin—lung cancer	8.12e-05	0.000454	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—lung cancer	8.01e-05	0.000448	CcSEcCtD
Etravirine—Convulsion—Methotrexate—lung cancer	7.97e-05	0.000446	CcSEcCtD
Etravirine—Vomiting—Etoposide—lung cancer	7.96e-05	0.000446	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—lung cancer	7.96e-05	0.000445	CcSEcCtD
Etravirine—Rash—Etoposide—lung cancer	7.9e-05	0.000442	CcSEcCtD
Etravirine—Dermatitis—Etoposide—lung cancer	7.89e-05	0.000441	CcSEcCtD
Etravirine—Headache—Etoposide—lung cancer	7.85e-05	0.000439	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—lung cancer	7.84e-05	0.000439	CcSEcCtD
Etravirine—Tension—Doxorubicin—lung cancer	7.81e-05	0.000437	CcSEcCtD
Etravirine—Vomiting—Paclitaxel—lung cancer	7.81e-05	0.000437	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.77e-05	0.000435	CcSEcCtD
Etravirine—Rash—Paclitaxel—lung cancer	7.74e-05	0.000433	CcSEcCtD
Etravirine—Dermatitis—Paclitaxel—lung cancer	7.74e-05	0.000433	CcSEcCtD
Etravirine—Discomfort—Methotrexate—lung cancer	7.73e-05	0.000433	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—lung cancer	7.73e-05	0.000433	CcSEcCtD
Etravirine—Headache—Paclitaxel—lung cancer	7.69e-05	0.00043	CcSEcCtD
Etravirine—Hypersensitivity—Docetaxel—lung cancer	7.67e-05	0.000429	CcSEcCtD
Etravirine—Confusional state—Methotrexate—lung cancer	7.57e-05	0.000423	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—lung cancer	7.5e-05	0.00042	CcSEcCtD
Etravirine—Asthenia—Docetaxel—lung cancer	7.47e-05	0.000418	CcSEcCtD
Etravirine—Infection—Methotrexate—lung cancer	7.45e-05	0.000417	CcSEcCtD
Etravirine—Nausea—Etoposide—lung cancer	7.44e-05	0.000416	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—lung cancer	7.39e-05	0.000413	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—lung cancer	7.36e-05	0.000412	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—lung cancer	7.36e-05	0.000412	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—lung cancer	7.35e-05	0.000411	CcSEcCtD
Etravirine—Nausea—Paclitaxel—lung cancer	7.3e-05	0.000408	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—lung cancer	7.29e-05	0.000408	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—lung cancer	7.25e-05	0.000406	CcSEcCtD
Etravirine—Malaise—Doxorubicin—lung cancer	7.18e-05	0.000402	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—lung cancer	7.15e-05	0.0004	CcSEcCtD
Etravirine—Anorexia—Methotrexate—lung cancer	7.15e-05	0.0004	CcSEcCtD
Etravirine—Syncope—Doxorubicin—lung cancer	7.14e-05	0.000399	CcSEcCtD
Etravirine—Diarrhoea—Docetaxel—lung cancer	7.12e-05	0.000398	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—lung cancer	7e-05	0.000391	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—lung cancer	6.9e-05	0.000386	CcSEcCtD
Etravirine—Dizziness—Docetaxel—lung cancer	6.88e-05	0.000385	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—lung cancer	6.87e-05	0.000384	CcSEcCtD
Etravirine—Insomnia—Methotrexate—lung cancer	6.79e-05	0.00038	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—lung cancer	6.75e-05	0.000378	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—lung cancer	6.74e-05	0.000377	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.73e-05	0.000377	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—lung cancer	6.7e-05	0.000375	CcSEcCtD
Etravirine—Somnolence—Methotrexate—lung cancer	6.67e-05	0.000373	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—lung cancer	6.63e-05	0.000371	CcSEcCtD
Etravirine—Vomiting—Docetaxel—lung cancer	6.62e-05	0.00037	CcSEcCtD
Etravirine—Rash—Docetaxel—lung cancer	6.56e-05	0.000367	CcSEcCtD
Etravirine—Dermatitis—Docetaxel—lung cancer	6.56e-05	0.000367	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—lung cancer	6.55e-05	0.000366	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—lung cancer	6.52e-05	0.000365	CcSEcCtD
Etravirine—Headache—Docetaxel—lung cancer	6.52e-05	0.000365	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—lung cancer	6.48e-05	0.000362	CcSEcCtD
Etravirine—Fatigue—Methotrexate—lung cancer	6.47e-05	0.000362	CcSEcCtD
Etravirine—Infection—Doxorubicin—lung cancer	6.45e-05	0.000361	CcSEcCtD
Etravirine—Pain—Methotrexate—lung cancer	6.42e-05	0.000359	CcSEcCtD
Etravirine—Shock—Doxorubicin—lung cancer	6.39e-05	0.000358	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—lung cancer	6.37e-05	0.000356	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—lung cancer	6.36e-05	0.000356	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—lung cancer	6.31e-05	0.000353	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—lung cancer	6.28e-05	0.000351	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—lung cancer	6.19e-05	0.000346	CcSEcCtD
Etravirine—Nausea—Docetaxel—lung cancer	6.18e-05	0.000346	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—lung cancer	6.18e-05	0.000346	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—lung cancer	6.14e-05	0.000343	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—lung cancer	5.93e-05	0.000332	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—lung cancer	5.93e-05	0.000332	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—lung cancer	5.88e-05	0.000329	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—lung cancer	5.83e-05	0.000326	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—lung cancer	5.78e-05	0.000323	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—lung cancer	5.65e-05	0.000316	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—lung cancer	5.61e-05	0.000314	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—lung cancer	5.6e-05	0.000313	CcSEcCtD
Etravirine—Constipation—Doxorubicin—lung cancer	5.56e-05	0.000311	CcSEcCtD
Etravirine—Pain—Doxorubicin—lung cancer	5.56e-05	0.000311	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—lung cancer	5.53e-05	0.000309	CcSEcCtD
Etravirine—Asthenia—Methotrexate—lung cancer	5.38e-05	0.000301	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—lung cancer	5.35e-05	0.0003	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—lung cancer	5.31e-05	0.000297	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—lung cancer	5.14e-05	0.000287	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—lung cancer	5.14e-05	0.000287	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—lung cancer	5.13e-05	0.000287	CcSEcCtD
Etravirine—Dizziness—Methotrexate—lung cancer	4.96e-05	0.000278	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—lung cancer	4.79e-05	0.000268	CcSEcCtD
Etravirine—Vomiting—Methotrexate—lung cancer	4.77e-05	0.000267	CcSEcCtD
Etravirine—Rash—Methotrexate—lung cancer	4.73e-05	0.000265	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—lung cancer	4.73e-05	0.000264	CcSEcCtD
Etravirine—Headache—Methotrexate—lung cancer	4.7e-05	0.000263	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—lung cancer	4.66e-05	0.000261	CcSEcCtD
Etravirine—Nausea—Methotrexate—lung cancer	4.46e-05	0.000249	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—lung cancer	4.45e-05	0.000249	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—lung cancer	4.3e-05	0.00024	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—lung cancer	4.13e-05	0.000231	CcSEcCtD
Etravirine—Rash—Doxorubicin—lung cancer	4.1e-05	0.000229	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—lung cancer	4.09e-05	0.000229	CcSEcCtD
Etravirine—Headache—Doxorubicin—lung cancer	4.07e-05	0.000228	CcSEcCtD
Etravirine—Nausea—Doxorubicin—lung cancer	3.86e-05	0.000216	CcSEcCtD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.31e-05	0.000301	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CNDP2—lung cancer	2.31e-05	0.0003	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM2—lung cancer	2.31e-05	0.0003	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.29e-05	0.000298	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AZIN2—lung cancer	2.29e-05	0.000298	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CNDP2—lung cancer	2.25e-05	0.000293	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM2—lung cancer	2.25e-05	0.000293	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTMR3—lung cancer	2.25e-05	0.000292	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CKB—lung cancer	2.24e-05	0.000291	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTMR3—lung cancer	2.19e-05	0.000285	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PGAM1—lung cancer	2.19e-05	0.000284	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.15e-05	0.000279	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PGAM1—lung cancer	2.14e-05	0.000278	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CNDP2—lung cancer	2.1e-05	0.000274	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM2—lung cancer	2.1e-05	0.000274	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.09e-05	0.000272	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2A7—lung cancer	2.09e-05	0.000271	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.08e-05	0.000271	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CA—lung cancer	2.06e-05	0.000267	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTMR3—lung cancer	2.05e-05	0.000266	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SDC4—lung cancer	2.04e-05	0.000266	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2A7—lung cancer	2.04e-05	0.000265	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.02e-05	0.000263	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.02e-05	0.000262	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PGAM1—lung cancer	2e-05	0.000259	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SDC4—lung cancer	1.99e-05	0.000259	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ATP5H—lung cancer	1.95e-05	0.000253	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—POMC—lung cancer	1.94e-05	0.000252	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.92e-05	0.00025	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2A7—lung cancer	1.9e-05	0.000247	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.87e-05	0.000243	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SDC4—lung cancer	1.86e-05	0.000242	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTA3—lung cancer	1.86e-05	0.000242	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—RRM1—lung cancer	1.86e-05	0.000242	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.82e-05	0.000237	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—RRM1—lung cancer	1.82e-05	0.000236	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTA3—lung cancer	1.82e-05	0.000236	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—B4GALT5—lung cancer	1.75e-05	0.000227	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLBD1—lung cancer	1.74e-05	0.000226	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.73e-05	0.000225	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.72e-05	0.000224	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—B4GALT5—lung cancer	1.71e-05	0.000222	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTA4—lung cancer	1.7e-05	0.000221	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—RRM1—lung cancer	1.7e-05	0.000221	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTA3—lung cancer	1.7e-05	0.000221	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—AKT1—lung cancer	1.68e-05	0.000218	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.68e-05	0.000218	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.66e-05	0.000216	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTA4—lung cancer	1.66e-05	0.000216	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTA2—lung cancer	1.66e-05	0.000216	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.64e-05	0.000213	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTA2—lung cancer	1.62e-05	0.00021	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTA1—lung cancer	1.6e-05	0.000208	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—B4GALT5—lung cancer	1.59e-05	0.000207	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSD17B10—lung cancer	1.59e-05	0.000206	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCC3—lung cancer	1.58e-05	0.000206	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTA1—lung cancer	1.56e-05	0.000203	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTA4—lung cancer	1.55e-05	0.000202	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.55e-05	0.000201	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ABCC3—lung cancer	1.54e-05	0.000201	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKR1C1—lung cancer	1.53e-05	0.000199	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.52e-05	0.000197	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTA2—lung cancer	1.51e-05	0.000197	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKR1C1—lung cancer	1.5e-05	0.000194	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—UGT1A1—lung cancer	1.49e-05	0.000193	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CKB—lung cancer	1.48e-05	0.000192	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTA1—lung cancer	1.46e-05	0.00019	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—UGT1A1—lung cancer	1.45e-05	0.000189	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCC3—lung cancer	1.44e-05	0.000187	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GNG11—lung cancer	1.43e-05	0.000186	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.43e-05	0.000185	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.42e-05	0.000185	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GNG11—lung cancer	1.4e-05	0.000182	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKR1C1—lung cancer	1.4e-05	0.000182	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM2—lung cancer	1.39e-05	0.00018	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CNDP2—lung cancer	1.39e-05	0.00018	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.38e-05	0.000179	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDOA—lung cancer	1.37e-05	0.000178	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—UGT1A1—lung cancer	1.36e-05	0.000176	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTMR3—lung cancer	1.35e-05	0.000176	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDOA—lung cancer	1.33e-05	0.000173	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOA3—lung cancer	1.33e-05	0.000172	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.32e-05	0.000172	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PGAM1—lung cancer	1.32e-05	0.000171	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GNG11—lung cancer	1.31e-05	0.00017	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.3e-05	0.000169	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.3e-05	0.000169	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOA3—lung cancer	1.29e-05	0.000168	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCG2—lung cancer	1.29e-05	0.000168	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADCY1—lung cancer	1.29e-05	0.000168	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ENO2—lung cancer	1.26e-05	0.000164	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HPGDS—lung cancer	1.26e-05	0.000164	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ABCG2—lung cancer	1.26e-05	0.000164	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADCY1—lung cancer	1.26e-05	0.000164	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.26e-05	0.000163	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2A7—lung cancer	1.26e-05	0.000163	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDOA—lung cancer	1.25e-05	0.000162	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.24e-05	0.000161	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ENO2—lung cancer	1.23e-05	0.00016	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HPGDS—lung cancer	1.23e-05	0.00016	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SDC4—lung cancer	1.23e-05	0.00016	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPP2R1B—lung cancer	1.23e-05	0.000159	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—lung cancer	1.23e-05	0.000159	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2A6—lung cancer	1.21e-05	0.000158	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GCLC—lung cancer	1.21e-05	0.000158	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOA3—lung cancer	1.21e-05	0.000157	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.21e-05	0.000157	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—lung cancer	1.2e-05	0.000156	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.19e-05	0.000154	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GCLC—lung cancer	1.18e-05	0.000154	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2A6—lung cancer	1.18e-05	0.000154	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADCY1—lung cancer	1.18e-05	0.000153	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCG2—lung cancer	1.18e-05	0.000153	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.16e-05	0.000151	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HPGDS—lung cancer	1.15e-05	0.00015	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ENO2—lung cancer	1.15e-05	0.00015	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ENO1—lung cancer	1.15e-05	0.000149	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.15e-05	0.000149	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.15e-05	0.000149	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.13e-05	0.000147	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.13e-05	0.000147	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ENO1—lung cancer	1.12e-05	0.000146	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.12e-05	0.000146	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—RRM1—lung cancer	1.12e-05	0.000145	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA3—lung cancer	1.12e-05	0.000145	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—lung cancer	1.12e-05	0.000145	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GCLC—lung cancer	1.11e-05	0.000144	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2A6—lung cancer	1.11e-05	0.000144	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.1e-05	0.000143	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.05e-05	0.000137	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.05e-05	0.000136	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ENO1—lung cancer	1.05e-05	0.000136	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.04e-05	0.000136	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2E1—lung cancer	1.03e-05	0.000134	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.03e-05	0.000134	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA4—lung cancer	1.02e-05	0.000133	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NQO1—lung cancer	1.02e-05	0.000133	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2E1—lung cancer	1.01e-05	0.000131	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.98e-06	0.00013	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA2—lung cancer	9.97e-06	0.00013	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NQO1—lung cancer	9.95e-06	0.000129	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.89e-06	0.000129	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA1—lung cancer	9.62e-06	0.000125	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCC3—lung cancer	9.51e-06	0.000124	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	9.49e-06	0.000123	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2E1—lung cancer	9.4e-06	0.000122	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NQO1—lung cancer	9.3e-06	0.000121	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKR1C1—lung cancer	9.21e-06	0.00012	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—STK11—lung cancer	9.19e-06	0.000119	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.1e-06	0.000118	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.02e-06	0.000117	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—STK11—lung cancer	8.97e-06	0.000117	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UGT1A1—lung cancer	8.94e-06	0.000116	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.63e-06	0.000112	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GNG11—lung cancer	8.62e-06	0.000112	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—lung cancer	8.5e-06	0.000111	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—STK11—lung cancer	8.38e-06	0.000109	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—lung cancer	8.3e-06	0.000108	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAT—lung cancer	8.27e-06	0.000108	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.23e-06	0.000107	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDOA—lung cancer	8.21e-06	0.000107	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAT—lung cancer	8.08e-06	0.000105	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCB1—lung cancer	8.05e-06	0.000105	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOA3—lung cancer	7.97e-06	0.000104	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TYMS—lung cancer	7.9e-06	0.000103	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.86e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—lung cancer	7.81e-06	0.000102	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADCY1—lung cancer	7.75e-06	0.000101	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCG2—lung cancer	7.75e-06	0.000101	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—lung cancer	7.75e-06	0.000101	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TYMS—lung cancer	7.71e-06	0.0001	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—lung cancer	7.63e-06	9.91e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HPGDS—lung cancer	7.61e-06	9.89e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ENO2—lung cancer	7.61e-06	9.89e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.56e-06	9.82e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAT—lung cancer	7.54e-06	9.81e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.5e-06	9.75e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1A1—lung cancer	7.41e-06	9.63e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—lung cancer	7.38e-06	9.59e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ERCC2—lung cancer	7.35e-06	9.55e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCB1—lung cancer	7.34e-06	9.54e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2A6—lung cancer	7.29e-06	9.48e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GCLC—lung cancer	7.29e-06	9.48e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1A1—lung cancer	7.23e-06	9.4e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TYMS—lung cancer	7.21e-06	9.37e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ERCC2—lung cancer	7.17e-06	9.32e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—lung cancer	7.12e-06	9.26e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ENO1—lung cancer	6.91e-06	8.98e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1A1—lung cancer	6.75e-06	8.78e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ERCC2—lung cancer	6.7e-06	8.71e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOA1—lung cancer	6.35e-06	8.26e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOA1—lung cancer	6.2e-06	8.06e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2E1—lung cancer	6.2e-06	8.06e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NQO1—lung cancer	6.13e-06	7.97e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.09e-06	7.91e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CG—lung cancer	5.8e-06	7.54e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOA1—lung cancer	5.79e-06	7.53e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CG—lung cancer	5.66e-06	7.36e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.55e-06	7.21e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—STK11—lung cancer	5.53e-06	7.18e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—POMC—lung cancer	5.52e-06	7.18e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—POMC—lung cancer	5.39e-06	7.01e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CREBBP—lung cancer	5.38e-06	6.99e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CG—lung cancer	5.29e-06	6.88e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CREBBP—lung cancer	5.25e-06	6.82e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—lung cancer	5.11e-06	6.65e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CD—lung cancer	5.1e-06	6.63e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—POMC—lung cancer	5.04e-06	6.55e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—lung cancer	5.03e-06	6.54e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CD—lung cancer	4.98e-06	6.47e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAT—lung cancer	4.98e-06	6.47e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—lung cancer	4.91e-06	6.39e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CREBBP—lung cancer	4.9e-06	6.38e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCB1—lung cancer	4.84e-06	6.29e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TYMS—lung cancer	4.75e-06	6.18e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—lung cancer	4.7e-06	6.11e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CD—lung cancer	4.65e-06	6.04e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—lung cancer	4.59e-06	5.97e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1A1—lung cancer	4.45e-06	5.79e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CB—lung cancer	4.45e-06	5.78e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ERCC2—lung cancer	4.42e-06	5.74e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—lung cancer	4.4e-06	5.73e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CB—lung cancer	4.34e-06	5.64e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—lung cancer	4.3e-06	5.59e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CB—lung cancer	4.05e-06	5.27e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—lung cancer	4.02e-06	5.22e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTEN—lung cancer	3.84e-06	4.99e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOA1—lung cancer	3.82e-06	4.97e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTEN—lung cancer	3.75e-06	4.87e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—EP300—lung cancer	3.66e-06	4.76e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—EP300—lung cancer	3.58e-06	4.65e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTEN—lung cancer	3.5e-06	4.55e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.49e-06	4.53e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—EP300—lung cancer	3.34e-06	4.34e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—POMC—lung cancer	3.32e-06	4.32e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CREBBP—lung cancer	3.23e-06	4.2e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CD—lung cancer	3.07e-06	3.99e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—lung cancer	3.03e-06	3.94e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—lung cancer	2.71e-06	3.52e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.67e-06	3.47e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—lung cancer	2.65e-06	3.44e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—lung cancer	2.65e-06	3.44e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—lung cancer	2.47e-06	3.21e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTEN—lung cancer	2.31e-06	3e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—lung cancer	2.21e-06	2.88e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—EP300—lung cancer	2.2e-06	2.86e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—lung cancer	2.16e-06	2.81e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—lung cancer	2.02e-06	2.62e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.63e-06	2.12e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—lung cancer	1.33e-06	1.73e-05	CbGpPWpGaD
